Trials / Not Yet Recruiting
Not Yet RecruitingNCT06426485
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
A Multicenter, Randomized Withdrawal, Double-blind, Parallel, Placebo-controlled Design Clinical Trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 736 (estimated)
- Sponsor
- Luye Pharma Group Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized withdrawal, double-blind, parallel, placebo-controlled design clinical trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets to evaluate the long-term efficacy and safety in the treatment of Chinese patients with depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Toludesvenlafaxine Hydrochloride Sustained-release Tablets | orally once a day |
| DRUG | placebo | orally once a day |
Timeline
- Start date
- 2024-05-30
- Primary completion
- 2027-02-28
- Completion
- 2027-06-30
- First posted
- 2024-05-23
- Last updated
- 2024-05-23
Source: ClinicalTrials.gov record NCT06426485. Inclusion in this directory is not an endorsement.